Exane Derivatives’s CoStar Group CSGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.21K Hold
20
﹤0.01% 490
2022
Q1
$1.33K Hold
20
﹤0.01% 782
2021
Q4
$1.58K Hold
20
﹤0.01% 678
2021
Q3
$1.72K Hold
20
﹤0.01% 814
2021
Q2
$1.71K Sell
20
-30
-60% -$2.59K ﹤0.01% 828
2021
Q1
$4.11K Sell
50
-4,250
-99% -$367K ﹤0.01% 633
2020
Q4
$397K Sell
4,300
-400
-9% -$35.1K 0.12% 202
2020
Q3
$399K Buy
4,700
+4,660
+11,650% +$371K 0.12% 158
2020
Q2
$2.84K Hold
40
﹤0.01% 484
2020
Q1
$2.35K Hold
40
﹤0.01% 488
2019
Q4
$2.6K Hold
40
﹤0.01% 478
2019
Q3
$2.37K Hold
40
﹤0.01% 477
2019
Q2
$2.21K Hold
40
﹤0.01% 503
2019
Q1
$1.86K Hold
40
﹤0.01% 452
2018
Q4
$1.35K Hold
40
﹤0.01% 553
2018
Q3
$1.68K Buy
+40
New +$1.71K ﹤0.01% 508

Other funds holding CSGP

Exane Derivatives's CSGP Position: Q2 2022 in Review

Exane Derivatives held its CoStar Group (CSGP) position steady in Q2 2022 at 20 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Exane Derivatives first reported a position in CSGP in Q3 2018 and has held it in 16 quarters since. The position peaked at $399K in Q3 2020. 590 funds tracked by Wall St. Rank hold CSGP as of Q2 2022.

  • Exane Derivatives held 20 shares of CoStar Group worth $1.21K as of Q2 2022.
  • Exane Derivatives left its CoStar Group share count unchanged in Q2 2022.
  • CoStar Group made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #490 holding.
  • Exane Derivatives first reported a position in CoStar Group in Q3 2018 and has held it in 16 quarters since.
  • Exane Derivatives's CoStar Group position peaked at $399K in Q3 2020.
  • 590 funds tracked by Wall St. Rank held CoStar Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.